Group 1 - The stock price of Wanbang Medical is reported at 45.68 yuan, down 0.85 yuan or 1.83% from the previous trading day [1] - The company reached a maximum price of 46.44 yuan and a minimum of 45.64 yuan during the trading session, with a trading volume of 15,766 hands and a transaction amount of 73 million yuan [1] - Wanbang Medical's main business includes pharmaceutical research services and clinical research services, operating in the healthcare service industry [1] Group 2 - As of the first half of 2025, the company reported total assets of 1.592 billion yuan and net assets of 1.505 billion yuan [1] - The latest semi-annual report shows that the company achieved operating revenue of 147 million yuan, a year-on-year decrease of 21.57% [1] - The net profit attributable to the parent company was 26.81 million yuan, down 51.28% year-on-year, while the net profit after deducting non-recurring gains and losses was 12.33 million yuan, a decrease of 70.17% [1] Group 3 - The net cash flow from operating activities was 12.54 million yuan, a decline of 55.20% year-on-year [1] - The basic earnings per share for the reporting period were 0.4 yuan, with a weighted average return on equity of 1.79% [1] - On August 26, the net outflow of main funds from Wanbang Medical was 1.0683 million yuan, accounting for 0.1% of the circulating market value [1]
万邦医药股价下跌1.83% 上半年净利润同比下滑51.28%